GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Short-Term Debt

Palisade Bio (STU:7NS0) Short-Term Debt : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Short-Term Debt?

Palisade Bio's Short-Term Debt for the quarter that ended in Mar. 2024 was €0.00 Mil.

Palisade Bio's quarterly Short-Term Debt declined from Sep. 2023 (€0.24 Mil) to Dec. 2023 (€0.15 Mil) and declined from Dec. 2023 (€0.15 Mil) to Mar. 2024 (€0.00 Mil).

Palisade Bio's annual Short-Term Debt increased from Dec. 2021 (€0.08 Mil) to Dec. 2022 (€0.08 Mil) and increased from Dec. 2022 (€0.08 Mil) to Dec. 2023 (€0.15 Mil).


Palisade Bio Short-Term Debt Historical Data

The historical data trend for Palisade Bio's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Short-Term Debt Chart

Palisade Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Short-Term Debt
0.86 0.08 0.08 0.15

Palisade Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.38 0.24 0.15 -

Palisade Bio Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Palisade Bio Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Palisade Bio's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Palisade Bio (STU:7NS0) Business Description

Traded in Other Exchanges
Address
5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (STU:7NS0) Headlines

No Headlines